Cathie Wood Nurix Therapeutics, Inc. Transaction History
Ark Investment Management LLC
- $11 Billion
- Q2 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 2,323,332 shares of NRIX stock, worth $51.6 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
2,323,332
Previous 2,635,338
11.84%
Holding current value
$51.6 Million
Previous $38.7 Million
25.16%
% of portfolio
0.44%
Previous 0.28%
Shares
11 transactions
Others Institutions Holding NRIX
# of Institutions
183Shares Held
66.3MCall Options Held
40.9KPut Options Held
106K-
Black Rock Inc. New York, NY6.82MShares$151 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.42MShares$98.2 Million6.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.99MShares$88.6 Million2.73% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$86.2 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$80.5 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.05B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...